Download in electronic PDF format for $35

Search the Complete Journal Archives

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding

Author(s):  Chan Debora Schotik

Issue:  Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue

Abstract:  Regulations for the use of bulk drugs in animals are unclear. In this article, the author focuses on US food and drug regulations, use of bulk drugs to compound for humans and animals, US Food and Drug Administration regulations governing the use of bulk drugs, and regulatory actions. Tables provide a list of proposed bulk drugs suitable for use in compounding for humans, drug products not to be used in compounding and drugs prohibited for extralabel use in food-producing animals.

Related Keywords: bulk drugs, food and drug regulations, medications for animals, regulatory issues, use of bulk drugs, veterinary compounding

Related Categories: LEGAL, VETERINARY, FDA

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Chan Debora Schotik Mar/Apr 2001 97 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S Mar/Apr 2001 101 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt Jan/Feb 2017 19-21 Buy
TPN Bulk Compounding from Bulk Drug Substances Chamallas Stanley N Sep/Oct 1998 347-349 Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E Sep/Oct 2014 379-380 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy